Erratum: Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 22 (9262-9267) DOI:10.1073/pnas.1104836108);Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 22, 2011, Pages 9262-9267

  Warner Schmidt, Jennifer L ^a   Vanover, Kimberly E ^b   Chen, Emily Y ^a   Marshall, John J ^a   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Intra Cellular Therapies Inc   (United States)

Author keywords

Citalopram; Fluoxetine; S100A10

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ANTIINFLAMMATORY AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; GAMMA INTERFERON; IBUPROFEN; IMIPRAMINE; NAPROXEN; P11 PROTEIN; PARACETAMOL; PROTEIN; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; ATTENUATION; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG RESPONSE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT;

MUS;

EID: 79959343388     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109215108     Document Type: Erratum

References (31)

1. Kessler RC, et al. (2007) Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6:168-176.
2. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR (2007) The STAR*D Project results: A comprehensive review of findings. Curr Psychiatry Rep 9:449-459. (Pubitemid 350284935)
3. Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: What can we learn from animal studies? Neurosci Biobehav Rev 29:891-909.
4. Irwin MR, Miller AH (2007) Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21:374-383.
5. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741.
6. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for proinflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12:561-578.
7. Svenningsson P, et al. (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311:77-80. (Pubitemid 43063061)
8. Warner-Schmidt JL, et al. (2010) A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry 68:528-535.
9. Warner-Schmidt JL, et al. (2009) Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 29:1937-1946.
10. Alexander B, et al. (2010) Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2(54): 54ra76.
11. Rush AJ, et al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry 163:1905-1917. (Pubitemid 44807782)
12. Slattery DA, Neumann I, Cryan JF (2010) Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat. J Psychopharmacol, in press.
13. Mayberg HS, et al. (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651-660. (Pubitemid 40320700)
14. Casanova E, et al. (2001) A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis 31:37-42. (Pubitemid 32927797)
15. Zhang Z, Hofmann C, Casanova E, Schütz G, Lutz B (2004) Generation of a conditional allele of the CBP gene in mouse. Genesis 40:82-89. (Pubitemid 39488504)
16. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29:571-625. (Pubitemid 40755457)
17. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547-569. (Pubitemid 40755456)
18. Kuno R, et al. (2006) The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res 1116:12-18. (Pubitemid 44485022)
19. Saha RN, Liu X, Pahan K (2006) Up-regulation of BDNF in astrocytes by TNF-alpha: A case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 1:212-222. (Pubitemid 44244127)
20. Bayas A, et al. (2002) Human cerebral endothelial cells are a potential source for bioactive BDNF. Cytokine 19:55-58.
21. Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P (2010) Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol Psychiatry 67:1048-1056.
22. Huang XL, et al. (2003) Interferon-gamma induces p11 gene and protein expression in human epithelial cells through interferon-gamma-activated sequences in the p11 promoter. J Biol Chem 278:9298-9308.
23. Song JH, et al. (2005) Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J Biol Chem 280:12896-12901.
24. Kim SJ, et al. (2007) Interferon-gamma promotes differentiation of neural progenitor cells via the JNK pathway. Neurochem Res 32:1399-1406. (Pubitemid 46988203)
25. Baron R, et al. (2008) IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J 22:2843-2852.
26. Warner-Schmidt JL, Duman RS (2006) Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 16:239-249.
27. O'Connor JC, et al. (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29:4200-4209.
28. Litteljohn D, et al. (2010) Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: Implications for psychological pathology. Brain Behav Immun 24:462-473.
29. Leuchter AF, et al. (2010) Painful physical symptoms and treatment outcome in major depressive disorder: A STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med 40:239-251.
30. Müller N, et al. (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680-684. (Pubitemid 43989814)
31. Opalka D, et al. (2003) Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol 10:108-115. (Pubitemid 36133838)